You'll have to read this yourself and see if it shows promise. At least it is for chronic so you don't have spontaneous recovery to confound the study.
The press release here;
Stem cell stroke treatment trial results 'show promise'
The trial itself here;
Pilot Investigation of Stem Cells in Stroke (PISCES)
Purpose
The
study is designed to test the safety of a manufactured neural stem cell
line (CTX cells) delivered by injection into the damaged brains of male
patients 60 years of age or over who remain moderately to severely
disabled 6 months to 5 years following an ischemic stroke. In addition
the trial will evaluate a range of potential efficacy measures for
future trials. Treatment will involve a single injection of one of four
doses of CTX cells into the patient's brain in a carefully controlled
neurosurgical operation performed under general anesthetic. The trial is
designed to treat 12 patients and measure outcomes over 24 months.
Patients will be invited to participate in a long-term follow-up trial
for a further 8 years.
No comments:
Post a Comment